Semax 10mg · Lyophilised Powder
Cognitive

Semax

10mg · Lyophilised Powder

$80 AUD

Third-party tested — independent batch verification
99%+ purity — HPLC & mass spectrometry confirmed
Batch certificate accessible via QR code
Fast, discreet shipping Australia-wide

For laboratory research use only. Not for human consumption. Must be handled by qualified researchers in accordance with applicable regulations.

Product

Overview

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the ACTH(4-7) sequence, to which a Pro-Gly-Pro C-terminal extension has been added to confer resistance to enzymatic degradation. Unlike native ACTH, Semax does not possess adrenocorticotropic activity. It was developed in Russia and has been investigated primarily for neuroprotective and cognitive research applications.

Research

Scientific Overview

Research has examined Semax in the context of neurotrophic factor modulation, neuroprotection, and cognitive function. Preclinical studies have demonstrated upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB following Semax administration. Research in ischaemia models has shown reduced infarct volume and improved neurological outcomes. Studies have also investigated its effects on dopaminergic and serotonergic transmission, attention, and learning paradigms in rodent models.

Biology

Mechanism of Action

Semax increases BDNF expression in the cortex, hippocampus, and basal forebrain via activation of the MAP kinase (ERK1/2) signalling cascade and CREB phosphorylation. Elevated BDNF supports synaptic plasticity, neuronal survival, and axonal branching. Semax also modulates the serotonergic and dopaminergic systems by influencing monoamine transporter expression and catecholamine turnover in prefrontal regions. In ischaemia models, it reduces oxidative damage to neurons by enhancing endogenous antioxidant enzyme expression and suppressing NF-kB-mediated inflammatory gene induction.

Science

Areas of Research

Cognitive Research Neuroprotection BDNF Biology Ischaemia Research Dopaminergic Research Serotonergic Research
Verification

Third-Party Testing

Every batch of Semax supplied by Pure Recovery Labs is independently analysed by a third-party laboratory prior to release. Purity is confirmed via HPLC and mass spectrometry to a minimum of 99%. A certificate of analysis is accessible via QR code on each product and through the Quality page.

View Certificates
Important

Research Use Only

Semax is supplied exclusively for in vitro and preclinical laboratory research. It is not intended for, and must not be used in, humans or animals. It is not a medicinal product, therapeutic agent, supplement, cosmetic, or food substance. All handling must comply with applicable institutional and regulatory requirements. Pure Recovery Labs makes no claims regarding therapeutic efficacy or safety in any biological system.